Meeder Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,628
| Closed | -$87K | – | 1199 |
|
|
2021
Q3 | $87K | Buy |
2,628
+952
| +57% | +$31.5K | ﹤0.01% | 935 |
|
|
2021
Q2 | $106K | Sell |
1,676
-2,531
| -60% | -$160K | ﹤0.01% | 891 |
|
|
2021
Q1 | $180K | Buy |
+4,207
| New | +$180K | 0.01% | 753 |
|
|
2020
Q3 | – | Sell |
-4,693
| Closed | -$153K | – | 2157 |
|
|
2020
Q2 | $153K | Buy |
4,693
+2,725
| +138% | +$88.8K | 0.01% | 655 |
|
|
2020
Q1 | $53K | Sell |
1,968
-1,687
| -46% | -$45.4K | ﹤0.01% | 890 |
|
|
2019
Q4 | $112K | Buy |
3,655
+3,360
| +1,139% | +$103K | 0.01% | 759 |
|
|
2019
Q3 | $7K | Sell |
295
-155
| -34% | -$3.68K | ﹤0.01% | 1631 |
|
|
2019
Q2 | $11K | Hold |
450
| – | – | ﹤0.01% | 1419 |
|
|
2019
Q1 | $9K | Buy |
450
+11
| +3% | +$220 | ﹤0.01% | 1258 |
|
|
2018
Q4 | $5K | Buy |
+439
| New | +$5K | ﹤0.01% | 1397 |
|
|
2018
Q3 | – | Sell |
-133
| Closed | -$2.93K | – | 1530 |
|
|
2018
Q2 | $2.93K | Buy |
+133
| New | +$2.93K | ﹤0.01% | 1361 |
|